Search Results

Developing robust formoterol-containing suspension pMDls with enhanced shelf lives.

• Authors : Slowey, Alex¹ ; Righton, Louise²; Bainbridge, Paul³

Subjects: FORMOTEROL; OBSTRUCTIVE lung diseases; ADRENOCORTICAL hormones

• Source: Pharmaceutical Technology Europe. Oct2009, Vol. 21 Issue 10, p54-58. 4p.

Record details

Budesonide plus formoterol associated with better control of persistent asthma control than gold standard therapy.

Subjects: FORMOTEROL; STEROID drugs; ASTHMA treatment

• Source: Formulary. Aug2007, Vol. 42 Issue 8, p490-493. 2p.

Record details

Advisory committee recommends continued marketing of beta2-agonists, black-box warning for formoterol.

Subjects: UNITED States. Food & Drug Administration. Pulmonary-Allergy Drugs Advisory Committee; FORMOTEROL; ADRENERGIC beta agonistsUNITED States

• Source: Formulary. Sep2005, Vol. 40 Issue 9, p311-311. 5/8p.

Record details

Single vs Multiple Inhaler Triple Therapy for COPD Could Triple Adherence, Persistence: International Data.

• Authors : Halsey, Grace

Subjects: CHRONIC obstructive pulmonary disease; NARRATIVE therapy; PATIENT compliance

• Source: Patient Care (Online); 10/12/2024, p3-3, 1p

Record details

FDA green-lights new bronchodilator.

Subjects: FORMOTEROL; DRUG laws; ADRENERGIC beta agonistsUNITED StatesUNITED States. Food & Drug Administration

• Source: Drug Topics. 11/6/2006, Vol. 150 Issue 21, p8-8. 1/9p.

Record details

COMMITTEE WEIGHS IN ON ASTHMA MEDS.

• Authors : Aungst, Heide

Subjects: ANTIASTHMATIC agents; FORMOTEROL; DRUG utilizationUNITED StatesUNITED States. Food & Drug Administration

• Source: Medical Economics. 1/23/2009, Vol. 86 Issue 2, p15-15. 1/5p.

Record details

New long-acting bronchodilator also provides rapid onset.

• Authors : Chernin, Tammy

Subjects: FORMOTEROL; ASTHMA treatmentNOVARTIS AG 001221845 NOVARTIS AG NOVARTIS AG 001221845 001221845 NOVARTIS AG 001221845 NVS

• Source: Drug Topics. 3/19/2001, Vol. 145 Issue 6, p15. 1p. 1 Color Photograph.

Record details

AstraZeneca Launches Phase 3 THARROS Trial of Breztri to Reduce Cardiopulmonary Events in COPD.

• Authors : Halsey, Grace

Subjects: CARDIOVASCULAR diseases; FORMOTEROL; CHRONIC obstructive pulmonary diseaseASTRAZENECA PLC

• Source: Patient Care (Online); 3/15/2024, p1-1, 1p, 1 Color Photograph

Record details

COMPARISON OF ASTHMA TREATMENT IN YOUNG AND ELDERLY PATIENTS.

Subjects: *FORMOTEROL; *ASTHMATICS; *CLINICAL trials

• Source: Pharmacy Times. Aug2011, Vol. 77 Issue 8, p64-64. 1/4p.

Record details

Symbicort.

Subjects: DRUG approval; EXPERIMENTAL therapeutics; ADRENOCORTICAL hormones

• Source: Formulary. Apr2009, Vol. 44 Issue 4, p101-101. 1/2p.

Record details